Industry: Chemical & Material
Published Date: 2026-04-21
Pages: 137 Pages
Report ld: 6548999
Request Sample
Customized Report
The global Finasteride API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Finasteride API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Finasteride API is a 5α-reductase inhibitor and therefore an antiandrogen.[9] It works by decreasing the production of dihydrotestosterone (DHT) by about 70%, including in the prostate gland and the scalp.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report delivers a comprehensive overview of the global Finasteride API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Finasteride API. The Finasteride API market size, estimates, and forecasts are provided in terms of output/shipments (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Finasteride API market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Finasteride API manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Finasteride API manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Finasteride API production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Finasteride API consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Finasteride API Market Overview
1.1 Product Definition
1.2 Finasteride API by Type
1.2.1 Global Finasteride API Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Abrove 99% Purity
1.2.3 99% Purity
1.2.4 Under 99% Purity
1.3 Finasteride API by Application
1.3.1 Global Finasteride API Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Pharmaceutical Industry
1.3.3 Research Organization
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Finasteride API Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Finasteride API Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Finasteride API Production Estimates and Forecasts (2021–2032)
1.4.4 Global Finasteride API Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Finasteride API Production Market Share by Manufacturers (2021–2026)
2.2 Global Finasteride API Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Finasteride API, Industry Ranking, 2024 vs 2025
2.4 Global Finasteride API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Finasteride API Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Finasteride API, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Finasteride API, Product Offerings and Applications
2.8 Global Key Manufacturers of Finasteride API, Date of Entry into the Industry
2.9 Finasteride API Market Competitive Situation and Trends
2.9.1 Finasteride API Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Finasteride API Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Finasteride API Production by Region
3.1 Global Finasteride API Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Finasteride API Production Value by Region (2021–2032)
3.2.1 Global Finasteride API Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Finasteride API by Region (2027–2032)
3.3 Global Finasteride API Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Finasteride API Production Volume by Region (2021–2032)
3.4.1 Global Finasteride API Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Finasteride API by Region (2027–2032)
3.5 Global Finasteride API Market Price Analysis by Region (2021–2032)
3.6 Global Finasteride API Production, Value, and Year-over-Year Growth
3.6.1 North America Finasteride API Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Finasteride API Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Finasteride API Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Finasteride API Production Value Estimates and Forecasts (2021–2032)
4 Finasteride API Consumption by Region
4.1 Global Finasteride API Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Finasteride API Consumption by Region (2021–2032)
4.2.1 Global Finasteride API Consumption by Region (2021–2026)
4.2.2 Global Finasteride API Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Finasteride API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Finasteride API Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Finasteride API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Finasteride API Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Finasteride API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Finasteride API Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Finasteride API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Finasteride API Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Finasteride API Production by Type (2021–2032)
5.1.1 Global Finasteride API Production by Type (2021–2026)
5.1.2 Global Finasteride API Production by Type (2027–2032)
5.1.3 Global Finasteride API Production Market Share by Type (2021–2032)
5.2 Global Finasteride API Production Value by Type (2021–2032)
5.2.1 Global Finasteride API Production Value by Type (2021–2026)
5.2.2 Global Finasteride API Production Value by Type (2027–2032)
5.2.3 Global Finasteride API Production Value Market Share by Type (2021–2032)
5.3 Global Finasteride API Price by Type (2021–2032)
6 Segment by Application
6.1 Global Finasteride API Production by Application (2021–2032)
6.1.1 Global Finasteride API Production by Application (2021–2026)
6.1.2 Global Finasteride API Production by Application (2027–2032)
6.1.3 Global Finasteride API Production Market Share by Application (2021–2032)
6.2 Global Finasteride API Production Value by Application (2021–2032)
6.2.1 Global Finasteride API Production Value by Application (2021–2026)
6.2.2 Global Finasteride API Production Value by Application (2027–2032)
6.2.3 Global Finasteride API Production Value Market Share by Application (2021–2032)
6.3 Global Finasteride API Price by Application (2021–2032)
7 Key Companies Profiled
7.1 AMRI
7.1.1 AMRI Finasteride API Company Information
7.1.2 AMRI Finasteride API Product Portfolio
7.1.3 AMRI Finasteride API Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 AMRI Main Business and Markets Served
7.1.5 AMRI Recent Developments/Updates
7.2 Mylan
7.2.1 Mylan Finasteride API Company Information
7.2.2 Mylan Finasteride API Product Portfolio
7.2.3 Mylan Finasteride API Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Mylan Main Business and Markets Served
7.2.5 Mylan Recent Developments/Updates
7.3 Accord Pharmaceuticals
7.3.1 Accord Pharmaceuticals Finasteride API Company Information
7.3.2 Accord Pharmaceuticals Finasteride API Product Portfolio
7.3.3 Accord Pharmaceuticals Finasteride API Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Accord Pharmaceuticals Main Business and Markets Served
7.3.5 Accord Pharmaceuticals Recent Developments/Updates
7.4 Sterling Spa
7.4.1 Sterling Spa Finasteride API Company Information
7.4.2 Sterling Spa Finasteride API Product Portfolio
7.4.3 Sterling Spa Finasteride API Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Sterling Spa Main Business and Markets Served
7.4.5 Sterling Spa Recent Developments/Updates
7.5 DEAFARMA
7.5.1 DEAFARMA Finasteride API Company Information
7.5.2 DEAFARMA Finasteride API Product Portfolio
7.5.3 DEAFARMA Finasteride API Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 DEAFARMA Main Business and Markets Served
7.5.5 DEAFARMA Recent Developments/Updates
7.6 Gadea Grupo Farmacéutico, S.L.U.
7.6.1 Gadea Grupo Farmacéutico, S.L.U. Finasteride API Company Information
7.6.2 Gadea Grupo Farmacéutico, S.L.U. Finasteride API Product Portfolio
7.6.3 Gadea Grupo Farmacéutico, S.L.U. Finasteride API Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Gadea Grupo Farmacéutico, S.L.U. Main Business and Markets Served
7.6.5 Gadea Grupo Farmacéutico, S.L.U. Recent Developments/Updates
7.7 Hetero
7.7.1 Hetero Finasteride API Company Information
7.7.2 Hetero Finasteride API Product Portfolio
7.7.3 Hetero Finasteride API Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Hetero Main Business and Markets Served
7.7.5 Hetero Recent Developments/Updates
7.8 Dr.Reddys Laboratories
7.8.1 Dr.Reddys Laboratories Finasteride API Company Information
7.8.2 Dr.Reddys Laboratories Finasteride API Product Portfolio
7.8.3 Dr.Reddys Laboratories Finasteride API Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Dr.Reddys Laboratories Main Business and Markets Served
7.8.5 Dr.Reddys Laboratories Recent Developments/Updates
7.9 Pharmaffiliates
7.9.1 Pharmaffiliates Finasteride API Company Information
7.9.2 Pharmaffiliates Finasteride API Product Portfolio
7.9.3 Pharmaffiliates Finasteride API Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Pharmaffiliates Main Business and Markets Served
7.9.5 Pharmaffiliates Recent Developments/Updates
7.10 Cipla
7.10.1 Cipla Finasteride API Company Information
7.10.2 Cipla Finasteride API Product Portfolio
7.10.3 Cipla Finasteride API Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 Cipla Main Business and Markets Served
7.10.5 Cipla Recent Developments/Updates
7.11 Henan Topfond
7.11.1 Henan Topfond Finasteride API Company Information
7.11.2 Henan Topfond Finasteride API Product Portfolio
7.11.3 Henan Topfond Finasteride API Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 Henan Topfond Main Business and Markets Served
7.11.5 Henan Topfond Recent Developments/Updates
7.12 Khonsu International
7.12.1 Khonsu International Finasteride API Company Information
7.12.2 Khonsu International Finasteride API Product Portfolio
7.12.3 Khonsu International Finasteride API Production, Value, Price, and Gross Margin (2021–2026)
7.12.4 Khonsu International Main Business and Markets Served
7.12.5 Khonsu International Recent Developments/Updates
7.13 Aurobindo Pharma
7.13.1 Aurobindo Pharma Finasteride API Company Information
7.13.2 Aurobindo Pharma Finasteride API Product Portfolio
7.13.3 Aurobindo Pharma Finasteride API Production, Value, Price, and Gross Margin (2021–2026)
7.13.4 Aurobindo Pharma Main Business and Markets Served
7.13.5 Aurobindo Pharma Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Finasteride API Industry Chain Analysis
8.2 Finasteride API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Finasteride API Production Modes and Processes
8.4 Finasteride API Sales and Marketing
8.4.1 Finasteride API Sales Channels
8.4.2 Finasteride API Distributors
8.5 Finasteride API Customer Analysis
9 Finasteride API Market Dynamics
9.1 Finasteride API Industry Trends
9.2 Finasteride API Market Drivers
9.3 Finasteride API Market Challenges
9.4 Finasteride API Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Finasteride API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 137
USD 3950.00
(Single User License)
The global Finasteride API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 154
USD 4900.00
(Single User License)
The global market for Finasteride API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 123
USD 3950.00
(Single User License)
The global market for Finasteride API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 99
USD 2900.00
(Single User License)
The global Finasteride API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 95
USD 4250.00
(Single User License)
Finasteride API is a 5α-reductase inhibitor and therefore an antiandrogen.[9] It works by decreasing the production of dihydrotestosterone (DHT) by about 70%, including in the prostate gland and the scalp.
Published Date: 2024-04-07
Pages: 111
USD 4900.00
(Single User License)
Finasteride API is a 5α-reductase inhibitor and therefore an antiandrogen.[9] It works by decreasing the production of dihydrotestosterone (DHT) by about 70%, including in the prostate gland and the scalp.
Published Date: 2024-02-19
Pages: 122
USD 3950.00
(Single User License)
Finasteride API is a 5α-reductase inhibitor and therefore an antiandrogen.[9] It works by decreasing the production of dihydrotestosterone (DHT) by about 70%, including in the prostate gland and the scalp.
Published Date: 2024-01-11
Pages: 97
USD 2900.00
(Single User License)
The global market for Finasteride API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 137
The global Finasteride API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 154
The global market for Finasteride API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 123
The global market for Finasteride API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 99
The global Finasteride API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 95
Finasteride API is a 5α-reductase inhibitor and therefore an antiandrogen.[9] It works by decreasing the production of dihydrotestosterone (DHT) by about 70%, including in the prostate gland and the scalp.
Published: 2024-04-07
Pages: 111
Finasteride API is a 5α-reductase inhibitor and therefore an antiandrogen.[9] It works by decreasing the production of dihydrotestosterone (DHT) by about 70%, including in the prostate gland and the scalp.
Published: 2024-02-19
Pages: 122
Finasteride API is a 5α-reductase inhibitor and therefore an antiandrogen.[9] It works by decreasing the production of dihydrotestosterone (DHT) by about 70%, including in the prostate gland and the scalp.
Published: 2024-01-11
Pages: 97
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now